A comparison of single dose dexmedetomidine with propofol for the prevention of emergence delirium after desflurane anaesthesia in children.
J K Makkar, N Bhatia, I Bala...
https://pubmed.ncbi.nlm.nih.gov/26444149Actively Recruiting
Led by Yuzuncu Yil University · Updated on 2025-08-27
80
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating ways to prevent emergence agitation, a common complication after rhinoplasty surgery, by comparing two medications: subanesthetic propofol and a single dose of dexmedetomidine. This interventional study uses a double-blind design involving 80 patients aged 18 to 65 years who are classified as ASA I-II. The study aims to determine which medication better reduces agitation after anesthesia. Participants will be randomly assigned to one of two groups. Both groups will receive standard general anesthesia with drugs including midazolam, fentanyl, propofol, and rocuronium, along with maintenance anesthesia using sevoflurane. One group will receive a 0.5 mcg/kg dexmedetomidine infusion over 10 minutes after nasal packing, while the other group will get a 0.5 mg/kg propofol intravenous bolus at the same time. Postoperative pain relief will use paracetamol and tramadol before surgery ends, and muscle relaxation will be reversed with sugammadex. During the study, patients will be closely monitored for agitation using the Richmond Agitation Sedation Scale one minute after extubation. Heart rate, blood pressure, and oxygen saturation will be tracked at various times before, during, and after surgery. Additional observations will include any involuntary movements, laryngospasm, nausea, vomiting, or low oxygen levels after extubation. Recovery time will also be recorded. All collected data will be analyzed to compare the effects of the two medications on emergence agitation.
CONDITIONS
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day (surgery day)
Participants undergo elective rhinoplasty with general anesthesia and receive either a 10-minute infusion of dexmedetomidine or a single IV bolus of propofol after nasal packing.
1 surgery visit including anesthesia and drug administration
Duration - 15 minutes post-extubation
Participants are monitored for emergence agitation and vital signs for 15 minutes after extubation, including assessment of heart rate, blood pressure, oxygen saturation, and any adverse events.
Continuous monitoring during immediate recovery period
Total: 1 location
1
Van Yüzüncü Yıl University
Van, Tuşba, Turkey (Türkiye), 65100
Actively Recruiting
M
Mehmet Emin Keskin, assistant professor
B
Bedrettin Bingöl, MD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J K Makkar, N Bhatia, I Bala...
https://pubmed.ncbi.nlm.nih.gov/26444149